Recent studies have demonstrated that tumor-derived IgA abrogates tumor growth through antigen-dependent redirection of Fcα/μ+ myeloid cells and antigen-independent, pIgR-mediated transcytosis (15). This evidence concerns the gene CD79A and neoplasm.